Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 28;15(6):627-629.
doi: 10.1016/j.jcin.2022.01.022. Epub 2022 Feb 23.

Illuminating the Path for Novel Peripheral Drug-Eluting Stents

Affiliations
Editorial

Illuminating the Path for Novel Peripheral Drug-Eluting Stents

Eric A Secemsky et al. JACC Cardiovasc Interv. .
No abstract available

Keywords: clinical trials; drug-eluting stent(s); peripheral vascular disease.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Secemsky is funded by National Institutes of Health/National Heart, Lung, and Blood Institute grant K23HL150290. He also receives funding support from the Food & Drug Administration, Harvard Medical School’s Shore Faculty Development Award, AstraZeneca, BD, Boston Scientific, Cook, CSI, Laminate Medical, Medtronic and Philips; and consults for Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Endovascular Engineering, Inari, Janssen, Medtronic, Philips, and VentureMed. Dr Kochar has reported that he has no relationships relevant to the contents of this paper to disclose.

Comment on

References

    1. Dumville JC, Lee AJ, Smith FB, Fowkes FG. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pract. 2004;54(508):826–831. - PMC - PubMed
    1. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. 2018;39(9):763–816. 10.1093/eurheartj/ehx095 - DOI - PubMed
    1. Bradbury AW, Adam DJ, Bell J, et al. , BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(5 Suppl):5S–17S. 10.1016/j.jvs.2010.01.073 - DOI - PubMed
    1. Katsanos K, Tepe G, Tsetis D, Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol. 2014;37(3):592–603. 10.1007/s00270-014-0876-3 - DOI - PubMed
    1. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G, VIVA Physicians. Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69(6):910–919. 10.1002/ccd.21104 - DOI - PubMed

LinkOut - more resources